Korro Bio KRRO
NASDAQ KRRO
$12.94 +0.01 (+0.08%)
As of: Sep 10, 2026 · 2:59 PM EDT

Korro Bio (KRRO) Retained Earnings (2018 - 2026)

Korro Bio's (KRRO) quarterly Retained Earnings came in at $525.8 million in Q2 2026, up 22.09% on a YoY basis from $430.7 million in Q2 2025, and up 0.52% quarter-over-quarter from $523.1 million in Q1 2026.

Analysis

Korro Bio (KRRO) Retained Earnings (2018 - 2026) Analysis & Trends

Korro Bio (KRRO) has reported Retained Earnings for 9 consecutive years, with $525.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Retained Earnings rose 22.09% year-over-year to $525.8 million; the trailing twelve-month figure through Jun 2026 stood at $525.8 million (up 22.09% YoY), and the FY2025 full-year result was $435.1 million, up 1.95% from the prior year.
  • Retained Earnings grew to $525.8 million in Q2 2026 per KRRO's latest filing, from $523.1 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $525.8 million in Q2 2026 and bottomed at -$101.8 million in Q4 2022.
  • Historically, Retained Earnings has averaged $368.4 million across 5 years, with a median of $388.2 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Retained Earnings sank 132.75% in 2022, then surged 446.56% in 2023.
  • Over 5 years, Retained Earnings stood at -$101.8 million in 2022, then soared by 446.56% to $352.9 million in 2023, then climbed by 20.92% to $426.7 million in 2024, then rose by 1.95% to $435.1 million in 2025, then rose by 20.85% to $525.8 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered $525.8 million, $523.1 million, and $435.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 207.01 Bn 193.02 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 179.98 Bn 176.80 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 131.45 Bn 123.60 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 82.02 Bn 74.03 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 60.35 Bn 55.16 Bn 1.37 Bn 558.00 Mn
6 Moderna 53.69 Bn 48.55 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 33.11 Bn 29.80 Bn 992.69 Mn -6.33 Bn
8 Biogen 31.93 Bn 30.64 Bn 1.96 Bn 20.97 Bn
9 Roivant Sciences 29.21 Bn 29.21 Bn 1.16 Mn 5.13 Bn
10 Korro Bio 227.98 Mn 112.95 Mn - 525.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 525.79 Mn
Mar 31, 2026 523.09 Mn
Dec 31, 2025 435.06 Mn
Sep 30, 2025 432.61 Mn
Jun 30, 2025 430.66 Mn
Mar 31, 2025 428.66 Mn
Dec 31, 2024 426.72 Mn
Sep 30, 2024 424.44 Mn
Jun 30, 2024 422.44 Mn
Mar 31, 2024 353.91 Mn
Dec 31, 2023 352.91 Mn
Sep 30, 2023 340.31 Mn
Jun 30, 2023 337.38 Mn
Mar 31, 2023 334.49 Mn
Dec 31, 2022 -101.83 Mn
Sep 30, 2022 326.62 Mn
Jun 30, 2022 320.97 Mn
Mar 31, 2022 316.40 Mn
Dec 31, 2021 310.94 Mn
Sep 30, 2021 305.66 Mn